Refractory Angina (Angina) Equipment
-
Manufactured by Shockwave Medical Inc.based in USA
Neovasc is focused on creating better outcomes for difficult-to-treat cardiology patients through the development of two novel products: Reducer™* for treatment of refractory angina and the Tiara™ System* for treatment of mitral valve regurgitation. Millions of patients worldwide with coronary artery disease who are not ...
-
Manufactured by Shockwave Medical Inc.based in USA
An effective percutaneous treatment for refractory angina, a severely debilitating condition that affects millions ...
-
Manufactured by XyloCor Therapeuticsbased in USA
XC001 is an investigational gene therapy for the treatment of patients with refractory angina with no treatment options. Patients who have exhausted pharmacologic options and are not eligible for PCI or coronary artery bypass grafts become sedentary because of their symptoms and this can exacerbate comorbidities causing rapid ...
-
Manufactured by Caladrius Biosciences, Inc.based in USA
No-option refractory disabling angina (NORDA) describes patients who have severe and disabling angina, which persists despite revascularization (e.g. bypass surgery or stenting) and optimal medical therapy. Refractory angina (RA) describes the small proportion of patients with angina who have ...
-
Manufactured by Caladrius Biosciences, Inc.based in USA
The CD34+ cell was discovered as a result of the deliberate search for a stem cell capable of stimulating the development and/or repair of blood vessels. All tissues in the human body maintain their function by replacing cells over time. In addition to the maintenance function, the body must also be capable of building new blood vessels after injury. A CD34+ cell is a stem cell that has the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you